Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004218-02
Application #
3209576
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1987-03-01
Project End
1990-02-28
Budget Start
1988-03-01
Budget End
1989-02-28
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Zaccheo, T S; Gonsalves, R A; Kream, R M (1993) Detection and estimation of mRNA levels using a nonlinear model in neurons labeled by in situ hybridization histochemistry. Neuroimage 1:151-61
Pierotti, A R; Lasdun, A; Ayala, J M et al. (1991) Endopeptidase-24.15 in rat hypothalamic/pituitary/gonadal axis. Mol Cell Endocrinol 76:95-103
Kest, B; Orlowski, M; Molineaux, C J et al. (1991) Antinociceptive properties of inhibitors of endopeptidase 24.15. Int J Neurosci 56:141-9
Molineaux, C J; Yu, B; Ayala, J M (1991) Distribution of endopeptidase-24.15 in rat brain nuclei using a novel fluorogenic substrate: comparison with endopeptidase-24.11. Neuropeptides 18:49-54
Genden, E M; Molineaux, C J (1991) Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats. Hypertension 18:360-5
Molineaux, C J; Ayala, J M (1990) An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins. J Neurochem 55:611-8
Lasdun, A; Reznik, S; Molineaux, C J et al. (1989) Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone. J Pharmacol Exp Ther 251:439-47
Orlowski, M; Michaud, C; Molineaux, C J (1988) Substrate-related potent inhibitors of brain metalloendopeptidase. Biochemistry 27:597-602
Molineaux, C J; Lasdun, A; Michaud, C et al. (1988) Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo. J Neurochem 51:624-33